Surgical Approach to Primary Cardiac Malignant Lymphoma Considering Early Initiation of Chemotherapy.
1/5 보강
A 67-year-old woman was referred for cardiac tumor.
APA
Saisho H, Tobinaga S, et al. (2026). Surgical Approach to Primary Cardiac Malignant Lymphoma Considering Early Initiation of Chemotherapy.. The Kurume medical journal. https://doi.org/10.2739/kurumemedj.MS721-4008
MLA
Saisho H, et al.. "Surgical Approach to Primary Cardiac Malignant Lymphoma Considering Early Initiation of Chemotherapy.." The Kurume medical journal, 2026.
PMID
41850813 ↗
Abstract 한글 요약
A 67-year-old woman was referred for cardiac tumor. Computed tomography scans revealed a large mass occupying the left atrium causing the left pulmonary vein obstruction and pulmonary congestion. Positron emission tomography / computed tomography (PET/CT) showed abnormal accumulation at the border between the left atrium and the left pulmonary vein orifices, and the invasion of the malignant cell to the left upper and lower pulmonary veins was highly suspected. Operative finding was that the tumor was attached to the left atrial posterior wall adjacent to the left pulmonary vein orifices and extended to the left upper pulmonary vein about 1 cm beyond the left upper pulmonary vein orifice. The tumor was not extended to the left lower pulmonary vein. Considering the possibility that the tumor was a sarcoma, for which chemotherapy was less effective, radical resection including left upper lobectomy and reconstruction of the left atrium was considered, but a rapid intra-operative histological exam revealed a malignant lymphoma. Therefore, surgery was performed to reduce the tumor as much as possible. The postoperative course was good and the patient was treated with chemotherapy, surviving for 18 months without any signs of recurrence.
🏷️ 키워드 / MeSH 📖 같은 키워드 OA만
🏷️ 같은 키워드 · 무료전문 — 이 논문 MeSH/keyword 기반
- A Phase I Study of Hydroxychloroquine and Suba-Itraconazole in Men with Biochemical Relapse of Prostate Cancer (HITMAN-PC): Dose Escalation Results.
- Impact of Comorbidities on Clinical Outcomes and Quality of Life of Patients With Hormone Receptor-Positive/Human Epidermal Growth Factor Receptor 2-Negative (HR+/HER2-) Advanced Breast Cancer Treated With Palbociclib in the POLARIS Study.
- Key Considerations for Targeting in Pancreatic Cancer: Potential Impact on the Treatment Paradigm.
- Overcoming Chemoresistance in Glioblastoma: Mechanisms, Therapeutic Strategies, and Functional Precision Medicine.
- Current Systemic Treatment Options for Advanced Pancreatic Cancer-An Overview Article.
- Balancing safety and efficacy of Bendamustine plus anti CD20 regimens in elderly patients (> 70 y) with follicular lymphoma: a tertiary academic center experience.